Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2003
05/08/2003US20030087836 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
05/08/2003US20030087826 Conjugates comprising two active agents
05/08/2003US20030087820 Novel exendin agonist formulations and methods of administration thereof
05/08/2003US20030087803 Insertion drugs into cells, tissue; therapy for brain disorders, central nervous system disorders
05/08/2003US20030087789 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
05/08/2003US20030087436 Process for the production of biologically active polymeric nanoparticle-nucleic acid conjugates
05/08/2003US20030087433 Activator protein for use in cell propagation and cosmetics
05/08/2003US20030087308 Detection of preferential particles in fluids; obtain milling fluid, reduce size of particle sample, screen sample in high throughput assay, monitor activity of particles in sample
05/08/2003US20030087302 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator
05/08/2003US20030087111 Encapsulation, isolation tissues, cells
05/08/2003US20030087034 Solvent spreading on substrate; controlled heat drying; sheet administering drugs, foods, cosmetics
05/08/2003US20030087023 Method of depositing particles with an electrostatic chuck
05/08/2003US20030087003 Protection from yeast, fungus, and mold growth
05/08/2003US20030086989 Morinda citrifolia enhanced lip treatment
05/08/2003US20030086986 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occurring plant compounds, extracts and derivatives
05/08/2003US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering
05/08/2003US20030086982 Additional substance is added to the spray-drying process in a dry form during spray-drying to prepare dry extract from liquid extract
05/08/2003US20030086978 Thermal stability, transparency, and photochromic property; to be used as optical materials such as an optical recording material, an optical switch, and the like
05/08/2003US20030086977 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
05/08/2003US20030086976 Pharmaceutical compositions for poorly soluble drugs
05/08/2003US20030086975 Method for making a porous Polymeric material
05/08/2003US20030086973 Systems, methods and apparatuses for manufacturing dosage forms
05/08/2003US20030086972 Time-release agents; drug delivery; therapy
05/08/2003US20030086971 For therapy of allergic and/or inflammatory conditions of the skin and airway passages
05/08/2003US20030086970 Delay release formulation of a non-steroidal anti-inflammatory drug (NSAID) and a mixture containing a prostaqlandin and one or more excipients; for therapy of osteoarthritis or rheumatoid arthritis
05/08/2003US20030086969 Ciprofoxacin-metronidazole antibiotic composition
05/08/2003US20030086967 Medicine stability; solubility in an oral cavity, and does not have uncomfortable tastes
05/08/2003US20030086966 Antihistamine formulations for soft gelatin dosage forms
05/08/2003US20030086965 Combination chemotherapy
05/08/2003US20030086964 Methods and compositions for polyene antibiotics with reduced toxicity
05/08/2003US20030086963 Dressings and bandages comprising same
05/08/2003US20030086961 Composition and method
05/08/2003US20030086960 For drug delivery
05/08/2003US20030086958 Drug delivery
05/08/2003US20030086956 Nontoxic pesticide, and method of using the same
05/08/2003US20030086948 For decreasing the effect of intestinal metabolism on a drug
05/08/2003US20030086899 Chondroitin sulfate containing viscoelastics for use in treating joints
05/08/2003US20030086895 For sustained release of the encapsulated therapeutic agent after administration
05/08/2003US20030086881 Antiinfective combinations and their use for the topical treatment of fungal infections of the toenails and fingernails
05/08/2003US20030086880 Antimicrobial artificial nail composition and methods for preparing and using same
05/08/2003US20030086877 Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments
05/08/2003US20030086876 Pharmaceutical formulation of fluticasone propionate
05/08/2003US20030086867 Blood clot-targeted nanoparticles
05/08/2003US20030085487 Apparatus and method for manufacturing encapsulated products
05/08/2003US20030085484 Tablet cryotechnology
05/08/2003US20030085480 Preparation of powder agglomerates
05/08/2003DE20219829U1 Vaccine formulation against bacterial, viral, mycotic, prion or parasitic infections, includes a combination of at least two paraben esters and 2-phenoxyethanol as preservative
05/08/2003CA2789114A1 Medical compositions for intravesical treatment of bladder cancer
05/08/2003CA2763676A1 A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
05/08/2003CA2466148A1 Medical compositions for intravesical treatment of bladder cancer
05/08/2003CA2466032A1 Methods and dosage forms for improving the bioavailability of therapeutic agents
05/08/2003CA2465405A1 Controlled release compositions for macrolide antimicrobial agents
05/08/2003CA2465401A1 Photosensitizer functionalised nanoparticles
05/08/2003CA2465369A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
05/08/2003CA2465140A1 Method for the treatment of overactive bladder
05/08/2003CA2464945A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003CA2464656A1 Spray drying methods and compositions thereof
05/08/2003CA2464487A1 Transdermal transport device with an electrolytic actuator
05/08/2003CA2464483A1 Microneedle transport device
05/08/2003CA2464475A1 Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use
05/08/2003CA2464346A1 Water-soluble polymer conjugates of retinoic acid
05/08/2003CA2463977A1 Method of treatment of vulval vestibulitis
05/08/2003CA2463158A1 Depot formulations of iloperidone and a star polymer
05/08/2003CA2458850A1 Fibrin nanoparticles and uses thereof
05/08/2003CA2450726A1 Cream for treating photoinduced skin damage comprising lipoic acid, coenzyme q-10 and acetyl-l-carnitine
05/07/2003EP1308500A1 Ophthalmic composition
05/07/2003EP1308171A1 Pharmaceutical compositions containing dds compounds
05/07/2003EP1308170A2 Dried blood factor composition comprising trehalose
05/07/2003EP1308169A1 Reservoir composition for the topical application of sparingly soluble drugs, their production and use
05/07/2003EP1308163A1 Endoparasiticidal gel composition
05/07/2003EP1308162A1 Pernasal preparation
05/07/2003EP1308160A1 Highly absorbable solid preparation
05/07/2003EP1308159A1 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation
05/07/2003EP1308156A1 Drug-containing solid dispersion having improved solubility
05/07/2003EP1307459A2 Indole compounds useful for the treatment of cancer
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1307282A1 Encapsulation of liquid template particles
05/07/2003EP1307243A2 A medicinal aerosol formulation
05/07/2003EP1307240A2 Radiolabelled metal transport protein as imaging agent
05/07/2003EP1307233A2 Therapeutic polyanhydride compounds for drug delivery
05/07/2003EP1307232A1 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
05/07/2003EP1307230A2 Enhancement of development of oviparous species by in ovo feeding
05/07/2003EP1307227A2 Pharmaceutical compositions
05/07/2003EP1307220A1 Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
05/07/2003EP1307202A1 Method for the treatment of overactive bladder
05/07/2003EP1307199A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
05/07/2003EP1307194A1 Fentanyl composition for nasal administration
05/07/2003EP1307192A1 New use of angiotensin ii antagonists
05/07/2003EP1307191A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/07/2003EP1307188A1 Cannabinoid drugs
05/07/2003EP1307187A2 Use of 13-cis retinoic acid for the treatment of emphysema
05/07/2003EP1307186A1 Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
05/07/2003EP1307182A2 Pharmaceutical composition for transdermal delivery of befloxatone
05/07/2003EP1307181A1 Novel compositions of minoxidil
05/07/2003EP1307180A1 A method of preparing a pharmaceutical composition
05/07/2003EP1307097A2 Improved solid pharmaceutical dosage formulation of hydrophobic drugs
05/07/2003EP1263447A4 Optically-active nanoparticles for use in therapeutic and diagnostic methods
05/07/2003EP1216043B1 Retard form containing alpha-lipoic acid (derivatives)
05/07/2003EP1210138A4 Controlled delivery of bisphosphonates
05/07/2003EP1180994B1 Method and device for producing a product made of strip tape, especially a medical product and/or a product containing active substances as well as fillable receptacles or pouches whose edges can be sealed
1 ... 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 ... 2991